SCHEMBL6993182

SCHEMBL6993182

CCOC(=O)[C@H](C)Oc1cc2c(cc1[N+](=O)[O-])CCCCC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
KDM4E B2RXH2 5/20 0.43
HPGD P15428 4/20 0.43
MAPT P10636 4/20 0.43
MAPK1 P28482 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
TSHR P16473 2/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.39
GPR174 Q9BXC1 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
GALR2 O43603 1/20 0.38
MITF O75030 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
HSP90AA1 P07900 1/20 0.38
XBP1 P17861 1/20 0.38
CCR6 P51684 1/20 0.38
TDP1 Q9NUW8 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6996661 1.00 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDMAPTMAPK1
SCHEMBL6994446 1.00 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDMAPTMAPK1
SCHEMBL6994344 1.00 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDMAPTMAPK1
SCHEMBL6995241 0.99 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDMAPTMAPK1
SCHEMBL6999500 0.96 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDMAPTMAPK1
SCHEMBL7708269 0.85 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDMAPTNPSR1
SCHEMBL6997005 0.85 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDMAPTMAPK1
SCHEMBL7704908 0.83 ALDH1A1 (0.39) ALDH1A1HPGDMAPTNPSR1L3MBTL1
SCHEMBL14553879 0.81 MAPT (0.43) ALDH1A1KDM4EMAPTL3MBTL1GPR174
SCHEMBL6999409 0.78 MAPT (0.47) ALDH1A1KDM4EHPGDMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed